Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IKBKB | O14920 | 3/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.46 |
| ▸ | APP | P05067 | 2/20 | 0.44 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.42 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.42 |
| ▸ | LTA4H | P09960 | 1/20 | 0.41 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.40 |
| ▸ | CHUK | O15111 | 1/20 | 0.40 |
| ▸ | IKBKG | Q9Y6K9 | 1/20 | 0.40 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.40 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.40 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.40 |
| ▸ | ASIC3 | Q9UHC3 | 1/20 | 0.40 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.40 |
| ▸ | FAAH | O00519 | 1/20 | 0.39 |
| ▸ | HPGDS | O60760 | 1/20 | 0.39 |
| ▸ | KDM1A | O60341 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30633034 | 0.80 | MEN1 (0.39) | LTA4HHPGDSADORA2AADORA1 | |
| SCHEMBL30632958 | 0.80 | ADRA1A (0.36) | LTA4HHPGDSADORA2AADORA1 | |
| SCHEMBL22058646 | 0.76 | LTA4H (0.40) | IKBKBCYP19A1APPLTA4HS1PR1 | |
| SCHEMBL29732980 | 0.73 | APP (0.63) | CYP19A1APPCYP2A6HSD17B1HSD17B2 | |
| SCHEMBL845603 | 0.73 | APP (0.63) | CYP19A1APPCYP2A6HSD17B1HSD17B2 | |
| SCHEMBL2581028 | 0.73 | CYP19A1 (0.64) | IKBKBCYP19A1APPPIK3CACHUK | |
| SCHEMBL5545113 | 0.71 | LTA4H (0.33) | LTA4HHPGDSADORA2AADORA1 | |
| SCHEMBL21535251 | 0.70 | PIK3R1 (0.58) | IKBKBAPPPIK3R1PIK3CACYP2A6 | |
| SCHEMBL403651 | 0.70 | CYP19A1 (0.60) | IKBKBCYP19A1APPPIK3CACHUK | |
| SCHEMBL29415478 | 0.70 | CYP19A1 (0.60) | IKBKBCYP19A1APPPIK3CACHUK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1082945-C | Alkoximino acetamide | BAYER AG (DE) | 2002-04-17 | — | — | CN | claimed |
| CN-1200725-A | Acylaminosalicyclic acid amide compound | BAYER AG (DE) | 1998-12-02 | — | — | CN | claimed |
| US-20200227644-A1 | ORGANIC LIGHT-EMITTING DIODE OPERABLE AT LOW VOLTAGE WITH HIGH EFFICIENCY AND LONG LIFETIME | SFC CO., LTD. (KR) | 2020-07-16 | — | — | US | disclosed |
| EP-3660934-A1 | ORGANIC LIGHT EMITTING ELEMENT CAPABLE OF DRIVING AT LOW VOLTAGE AND HAVING HIGH EFFICIENCY AND LONG LIFE CHARACTERISTICS | SFC Co., Ltd. (KR) | 2020-06-03 | — | — | EP | disclosed |
| US-20180072753-A1 | NOVEL ORGANIC HETEROCYCLIC COMPOUND AND LIGHT-EMITTING DEVICE COMPRISING SAME | SFC CO., LTD. (KR) | 2018-03-15 | — | — | US | disclosed |
| CN-1938278-B | Process for producing 5-hydroxy-4-thiomethylpyrazole compound | IHARA CHEMICAL IND CO | 2012-12-12 | — | — | CN | disclosed |
| CN-102811713-A | Multifunctional Zwitterionic Polymer Conjugates | OLIGASIS | 2012-12-05 | — | — | CN | disclosed |
| CN-1993362-B | Fused Heterocyclic Compounds | TAKEDA PHARMACEUTICAL | 2010-12-15 | — | — | CN | disclosed |
| CN-100372840-C | Intermediate for the preparation of epimino | BAYER AG (DE) | 2008-03-05 | — | — | CN | disclosed |
| CN-100351237-C | Heterocyclic compounds, process for their preparation, pharmaceutical compositions containing them and their use in medicine | CADILA HEALTHCARE LTD (IN) | 2007-11-28 | — | — | CN | disclosed |
| CN-1247541-C | Cyclic imines as pesticides | BAYER AG (DE) | 2006-03-29 | — | — | CN | disclosed |
| CN-1704406-A | Intermediate for the preparation of epimino | BAYER AG (DE) | 2005-12-07 | — | — | CN | disclosed |
| CN-1681498-A | Diaryl ethers as opioid receptor antagonist | LILLY CO ELI (US) | 2005-10-12 | — | — | CN | disclosed |
| CN-1642918-A | Novel hererocyclic compound and preparation thereof and medicine composition containing same and use thereof in medicine | CADILA HEALTHCARE LTD (IN) | 2005-07-20 | — | — | CN | disclosed |
| CN-1082945-C | Alkoximino acetamide | BAYER AG (DE) | 2002-04-17 | — | — | CN | disclosed |
| US-6225334-B1 | AS PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2001-05-01 | — | — | US | disclosed |
| CN-1244860-A | Cyclic imines as pesticides | BAYER AG (DE) | 2000-02-16 | — | — | CN | disclosed |
| CN-1200725-A | Acylaminosalicyclic acid amide compound | BAYER AG (DE) | 1998-12-02 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180072753-A1 | NOVEL ORGANIC HETEROCYCLIC COMPOUND AND LIGHT-EMITTING DEVICE COMPRISING SAME | OR10J3, CRY1, NR2E3 | IKBKB 3388/4885CYP19A1 68/4885APP 1427/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.